The pharmacologic fate of 2,5-diaziridinyl-3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ NSC-182986) by intracarotid or intravenous administration in beagles
- 1 January 1983
- journal article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 1 (3) , 219-224
- https://doi.org/10.1007/bf00165606
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Intracerebral penetration and tissue distribution of 2,5-diaziridinyl 3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ, NSC-182986)Journal of Neuro-Oncology, 1983
- A PHASE-I STUDY OF INTRA-CAROTID ARTERY INFUSION OF CIS-DIAMMINEDICHLOROPLATINUM(II) IN PATIENTS WITH RECURRENT MALIGNANT INTRA-CEREBRAL TUMORS1982
- INTRA-ARTERIAL BCNU CHEMOTHERAPY FOR THE TREATMENT OF MALIGNANT GLIOMAS OF THE CENTRAL NERVOUS-SYSTEM - A PRELIMINARY-REPORT1981
- PHASE-I STUDY OF AZIRIDINYLBENZOQUINONE (NSC 182986)1981
- Potential CNS Antitumor Agents VI: Aziridinylbenzoquinones IIIJournal of Pharmaceutical Sciences, 1979
- Pharmacokinetics of intracarotid artery 14C-BCNU in the squirrel monkeyJournal of Neurosurgery, 1978
- Physicochemical considerations and pharmacokinetic behavior in delivery of drugs to the central nervous system.1977
- Theoretic limitations of intracarotid infusions in brain tumor chemotherapy.1977
- Potential central nervous system antitumor agents. Aziridinylbenzoquinones. 2Journal of Medicinal Chemistry, 1976
- Percutaneous Intra-arterial Chemotherapy in the Treatment of Intra-cranial Neoplasms: A review of 36 casesThe British Journal of Radiology, 1967